Targeting Isoprenylcysteine Carboxyl Methyltransferase to Overcome Resistance and Improve Responses in Chronic Myeloid Leukemia.

被引：0
|
作者：
Sun, Wen Tian [1 ]
Ng, Bee Ling
Yang, Li Yi
Wang, Mei [1 ]
Hwang, William [2 ]
Melo, Junia V. [3 ]
Druker, Brian J. [4 ]
Casey, Patrick J. [1 ]
Chuah, Charles [2 ]
机构：
[1] Duke NUS Grad Med Sch, Program Canc & Stem Cell Biol, Singapore, Singapore
[2] Singapore Gen Hosp, Duke NUS Grad Med Sch, Singapore 0316, Singapore
[3] Inst Med & Vet Sci, Adelaide, SA 5000, Australia
[4] Oregon Hlth & Sci Univ, Knight Canc Inst, Portland, OR 97201 USA
来源：
BLOOD | 2009年 / 114卷 / 22期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1267 / 1267
页数：1
相关论文
共 50 条
  • [1] Molecular resistance to imatinib in chronic myeloid leukemia. From the Italian Cooperative Study Group on chronic myeloid leukemia.
    Martinelli, G
    Soverini, S
    Rosti, G
    Bassi, S
    Amabile, M
    Trabacchi, E
    Giannini, B
    Cilloni, D
    Izzo, B
    de Vivo, A
    Testoni, N
    Cambrin, GR
    Bonifazi, F
    Luatti, S
    Gottardi, E
    Alberti, D
    Pane, F
    Salvatore, F
    Saglio, G
    Baccarani, M
    BLOOD, 2003, 102 (11) : 312B - 312B
  • [2] Mitochondria-specific targeting to overcome imatinib resistance in chronic myeloid leukemia cells
    Hekmatshoar, Y.
    Ozkan, T.
    Karabay, A. Z.
    Koc, A.
    Gurel, A. Karadag
    Vignais, M. -L.
    Sunguroglu, A.
    TOXICOLOGY LETTERS, 2024, 399 : S91 - S91
  • [3] Chronic myeloid leukemia. Genetic mechanisms of resistance to Imatinib
    Bengio, Raquel M.
    Gargallo, Patricia
    Barreyro, Paula
    Bitton, Roberto
    Larripa, Irene
    MEDICINA-BUENOS AIRES, 2007, 67 : 71 - 74
  • [4] Proteomics in Chronic Myeloid Leukemia.
    Pizzatti, L
    Sá, LA
    Deterling, LC
    Sousa, JM
    Abdelhay, E
    BLOOD, 2001, 98 (11) : 266B - 266B
  • [5] Models of chronic myeloid leukemia.
    Van Etten R.A.
    Current Oncology Reports, 2001, 3 (3) : 228 - 237
  • [6] POLYCOMB GENES IN CHRONIC MYELOID LEUKEMIA. A POSSIBLE MARKER OF RESISTANCE
    Bono, C.
    Guerrini, F.
    Barate, C.
    Franciosa, M.
    Santo, I.
    Votto, A.
    Ricci, F.
    Sicuranza, A.
    Raspadori, D.
    Tusa, I.
    Rovida, E.
    Dello Sbarba, P.
    Bocchia, M.
    Galimberti, S.
    HAEMATOLOGICA, 2024, 109 : 66 - 66
  • [7] Targeting metabolic vulnerabilities to overcome resistance to therapy in acute myeloid leukemia
    Sharma, Priyanka
    Borthakur, Gautam
    CANCER DRUG RESISTANCE, 2023, 6 (03) : 567 - 589
  • [8] Targeting the BCR-ABL tyrosine kinase in chronic myeloid leukemia.
    Goldman, JM
    Melo, JV
    NEW ENGLAND JOURNAL OF MEDICINE, 2001, 344 (14): : 1084 - 1086
  • [9] Targeting histone methylation to overrule transcriptionally driven drug resistance in myeloid leukemia.
    van Gils, Noortje
    Verhagen, Han J. M. P.
    Martianez, Tania
    Denkers, Fedor
    Vermue, Eline
    Rutten, Arjo
    Csikos, Tamas
    Cil, Meyrem
    Al, Marjon
    van Gemert, Frank
    Janssen, Jeroen J. W. M.
    Ossenkoppele, Gert J.
    Menezes, Renee X.
    Smit, Linda
    CANCER RESEARCH, 2020, 80 (21)
  • [10] Unswitch-ABL Drugs Overcome Resistance in Chronic Myeloid Leukemia
    Packer, Leisl
    Marais, Richard
    CANCER CELL, 2011, 19 (04) : 435 - 437
12345